Navigation Links
New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
Date:9/16/2013

NEW YORK, September 16, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Investors' Reports announced new research reports highlighting Merck & Co. Inc. (NYSE: MRK), Allergan Inc. (NYSE: AGN), Mylan, Inc. (NASDAQ: MYL), AstraZeneca PLC (NYSE: AZN), and GlaxoSmithKline plc (NYSE: GSK). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Merck & Co. Inc. Research Report

On September 9, 2013, Merck & Co. Inc. (Merck) announced that its New Drug Application (NDA) for the investigational fertility treatment, corifollitropin alfa, has received acceptance for standard review by the US Food and Drug Administration (FDA). Further, Merck stated that it is seeking FDA approval of corifollitropin alfa for Controlled Ovarian Stimulation (COS) in women participating in assisted reproductive technology, which if approved, will mark corifollitropin alfa as the first sustained follicular stimulant for use in a fertility treatment regimen. Barbara Stegmann, M.D., Reproductive Endocrinology and Infertility Specialist, and Principal Scientist and Clinical Lead Fertility, Merck, said, "The filing of corifollitropin alfa is an example of Merck's commitment to patients and scientific innovation." The Full Research Report on Merck & Co. Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
2. Research and Markets: Nanobiotechnology Applications, Markets and Companies - 2013 Report
3. Carbon Nanotubes (CNT) for Electronics & Electrics 2013-2023: Forecasts, Applications, Technologies
4. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
5. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
6. SpermCheck® Fertility, the Only FDA Approved At-Home Screening Test for Men to Determine Normal or Low Sperm Count, Now Available to Couples Planning or Struggling to Conceive
7. K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court
8. K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court
9. Pinnaclife Animal Health Features Seal N Heal Wound Shield in New Veterinary Dermatologist Tested and Approved Product Line!
10. Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
11. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 30, 2015   Pharnext SAS today announced ... for the treatment of Charcot-Marie-Tooth Type 1A (CMT1A), is being ... 2015 Peripheral Nerve Society (PNS) Biennial Meeting at the Quebec ... June 27 - July 2, 2015. At Poster ... July 1, 5p.m. to 7p.m. EDT: Poster ...
(Date:6/29/2015)... ... June 29, 2015 , ... The global microfluidics market ... forecast period (2015 to 2020). The market is mainly driven by the rising ... for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets, ...
(Date:6/29/2015)... 2015  AACC, a global scientific and medical ... medicine, is pleased to announce that the impact ... has increased to 7.9 in the 2014 Thomson ... Clinical Chemistry in the top 3% of ... of the research it publishes on laboratory medicine ...
(Date:6/29/2015)... 2015  Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical ... molecule and cell therapy treatments for central nervous system ... listing on the NASDAQ Capital Market under the symbol ... on the NYSE MKT until the market close on ... is expected to commence on July 13, 2015. ...
Breaking Biology Technology:Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3
... Green Bay, Wis - Mark Green's economic ... sweeping proposal would eliminate the state Department of Commerce ... ,Amid a series of ideas that include revenue caps, employer ... in much the same way that Indiana Gov. Mitch ...
... Madison, Wis. - Small businesses interested in tapping into ... able to learn what it takes to win these competitive ... in the entrepreneurial sector are encouraged to attend the ... 9 at the Hilton Milwaukee City Center . , ...
... to ramp up soybean oil production for use in ... , ,The state grant, presented this week to Quality ... than double its capacity to produce soybean oil, and ... like Renewable Alternatives. , ,Quality Roasting's soybean crushing operation ...
Cached Biology Technology:Green economic plan takes cue from Indiana 2Green economic plan takes cue from Indiana 3Green economic plan takes cue from Indiana 4Wisconsin's biodiesel network expands 2
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market announces that ... featured segment on "Money on the Mark", scheduled to air ... June 20 th . The ... be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO ...
(Date:6/16/2015)... June 16, 2015 /CNW Telbec/ - handyem Inc. ... around the incorporation of handyem,s HPC-150 portable flow ... the Mo-POD™. This unprecedented model of mobile laboratory ... at the Pennsylvania Convention ... 15 th to 18 th 2015. ...
(Date:6/15/2015)... 15, 2015 A new report [ ... the majority of US consumers using mobile banking applications want ... as fingerprint and voiceprint, instead of having to prove who ... Telstra,s " Mobile Identity   -   The Fusion of ... smartphones now the primary channel used by Gen X and ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... DE This month, Molecular Pharmaceutics ... Childhood Cancer Research and the Materials Science and ... the potential for nanotechnology to deliver chemotherapeutic agents ... harming healthy cells. To date, nanoparticle-based drug delivery ...
... For the first time, researchers have demonstrated that the ... glioblastoma virotherapy, a novel way of treating malignant brain ... A number of clinical trials are currently underway to ... research led by E. Antonio Chiocca, MD, PhD, chairman ...
... the University of Southampton has shown that copper ... contributed to the increasing number of antibiotic-resistant infections ... is largely responsible for the development of antibiotic-resistance, ... difficult-to-treat healthcare-associated infections (HCAIs). The newly-published paper, ...
Cached Biology News:Nanotechnology drug delivery shows promise for treatment of pediatric cancer 2New study shows how copper restricts the spread of global antibiotic-resistant infections 2
NF kappa B Related Sampler Kit 10g each...
Homo sapiens MEP50 protein, mRNA...
Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Biology Products: